Pharmacyclics

Patent cliffs & loss of exclusivity

Small Molecules

Company

Legal NamePharmacyclics Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/pharmacyclics
LinkedIn URLhttps://www.linkedin.com/company/pharmacyclics
Pitchbook URLhttps://pitchbook.com/profiles/company/41046-76
Stock SymbolPCYC
Twitter URLhttps://twitter.com/Pharmacyclics
Official Websitehttp://pharmacyclics.com

7 upcoming patent cliffs

DrugIngredientTypeCliff
  1. IMBRUVICAIBRUTINIBSmall mol.Apr 2035
  2. IMBRUVICAIBRUTINIBSmall mol.Apr 2035
  3. IMBRUVICAIBRUTINIBSmall mol.Sep 2036
  4. IMBRUVICAIBRUTINIBSmall mol.Sep 2036
  5. IMBRUVICAIBRUTINIBSmall mol.Sep 2036
  6. IMBRUVICAIBRUTINIBSmall mol.Sep 2036
  7. IMBRUVICAIBRUTINIBSmall mol.Jun 2039

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Pharmacyclics — patent cliffs & loss of exclusivity | CliffBio